May 15, 2017 – Faculty from the Cardiovascular Research Foundation (CRF) will be presenting research and lectures at EuroPCR 2017 taking place May 16-19 at the Palais des Congrès in Paris, France. They will be sharing the latest research and information on bioresorbable vascular scaffolds, imaging technologies, transcatheter aortic valve replacement, heart failure and other topics.

CRF faculty are world-renowned experts in the field of interventional cardiovascular medicine. Research presentations include the following:  

Tuesday, May 16, 2017

Euro17A-OP0530 - Multicenter evaluation of a novel 120µm DeSolve CX BRS: first report of six-month clinical and imaging endpoints

Session: Evolving BRS technology (comprising selected EuroPCR 2017 late-breaking trial submissions)

12:26 PM – 12:39 PM; Level 3, Room 351

Alexandre Abizaid, MD, PhD

Euro17LBT-OP0080 - The FANTOM II study: first report for the 12-month clinical outcomes of the Fantom sirolimus eluting bioresorbable scaffold

Session: Evolving BRS technology (comprising selected EuroPCR 2017 late-breaking trial submissions)

12:52 PM – 1:05 PM; Level 3, Room 351

Alexandre Abizaid, MD, PhD

Wednesday, May 17, 2017

Euro17LBT-OP0053 - Pressure wire compared with microcatheter-based evaluation of coronary fractional flow reserve measurements (PERFORM)

Session: FFR: trials and new techniques (Comprising selected EuroPCR 2017 CV Pipeline submissions)

3:39 PM – 3:57 PM; Level 3, Room 351

Ziad A. Ali, MD, DPhil

Thursday, May 18, 2017

Euro17A-OP1140 - Clinical and imaging predictors of permanent pacemaker implantation after TAVI:  an analysis from the PARTNER II SAPIEN 3 study

Session: The impact of conduction disturbances following TAVI (comprising selected EuroPCR 2017 abstract submissions)

9:22 AM – 9:35 AM; Level 3, Room 342B

Tamim Nazif, MD

Euro17A-OP0500 - Compliance with and impact of following a specific OCT stent implantation algorithm: an ILUMIEN III substudy

Session: OCT and IVUS imaging for evaluation of stent-based therapies (comprising selected EuroPCR 2017 late-breaking trial submissions)

10:43 AM – 10:56 AM; Level 2, Room 252A

Mitsuaki Matsumura

Euro17IN-OP0026 - Reinventing the heart valve: bioabsorbable valves enabling cardiovascular restoration

Session: First-in-man studies in tricuspid intervention and myocardial protection (comprising selected EuroPCR 2017 CV Pipeline submissions)

3:37 PM – 3:50 PM, Level 2, Room Maillot

Martin B. Leon, MD

 

CRF faculty will also be delivering lectures on a variety of topics in the field such as:

Wednesday, May 17, 2017

Critical appraisal of device based interventions in chronic heart failure: opportunities, challenges, and priorities

Session: Device-based management in advanced chronic heart failure: update on clinical development and outcomes

8:35 AM – 8:55 AM; Level 2, Room 242B

Daniel Burkhoff, MD, PhD

Future perspective and potential applications in the interventional arena

Session: Bioresorbable valve therapy: tomorrow's world

9:38 AM – 9:54 AM, Level 3, Room 351

Martin B. Leon, MD

A standardized approach for imaging the tricuspid valve

Session: Tricuspid regurgitation: surgical and transcatheter treatment options

11:07 AM – 11:23 AM; Level 2, Room 241

Rebecca T. Hahn, MD

The ILUMIEN IV trial: OCT guided PCI vs. angiography - An outcome study

Session: Planned and ongoing clinical trials on coronary interventions and imaging

1:52 PM – 2:05 PM; Level 3, Room 343

Ziad A. Ali, MD, DPhil

ECLIPSE - Evaluation of treatment strategies for severe calcific coronary arteries: orbital atherectomy vs. conventional angioplasty technique prior to implantation of DES

Session: Planned and ongoing clinical trials on coronary interventions and imaging

2:18 PM – 2:31 PM; Level 3, Room 343

Gregg W. Stone, MD

Thursday, May 18, 2017

New software to assist the interventional cardiologist in practice

Session: How intravascular imaging can optimize PCI results

11:35 AM – 11:55 AM; Level 2, Room 242B

Ziad A. Ali, MD, DPhil

TAVR UNLOAD trial - TAVR to unload the left ventricle in patients with advanced heart failure: a randomized controlled trial

Session: Planned and ongoing clinical trials on valvular intervention

1:52 PM – 2:05 PM; Level 3, Room 343

Martin B. Leon, MD

Design considerations in functional mitral regurgitation trials

Session: Planned and ongoing clinical trials on valvular intervention

2:05 PM – 2:18 PM; Level 3, Room 343

Ori Ben-Yehuda, MD

The SCOUT II trial: European study to evaluate the Mitralign tricuspid valve annuloplasty system (PTVAS) for symptomatic chronic functional tricuspid regurgitation

Session: Planned and ongoing clinical trials on valvular intervention

Rebecca T. Hahn, MD

2:18 PM – 2:31 PM; Level 3, Room 343

Anatomy of the mitral valve – what interventionists need to know

Session: Transcatheter treatment of mitral regurgitation

Rebecca T. Hahn, MD

2:50 PM – 3:06 PM; Level 3, Theatre Bordeaux

Monitoring fluid status of patients with heart failure using REDS technology: implications for the continuum of care environments

Session: Latest in device-based heart failure management: from concept to FIM

Daniel Burkhoff, MD, PhD

3:23 PM – 3:39 PM; Level 3, Room 351

 

To learn more about CRF’s research and educational programs at EuroPCR, visit Booth M7 (Level 2).

 

Press Contacts

Irma Damhuis
Director, External Relations
Tel: 646-434-4690
Email: idamhuis@crf.org

Judy Romero
Program Manager, External Relations
Tel: 646-434-4608
Email: jromero@crf.org

Eucomed Guidelines go into effect
1 January 2018, update your TCTMD profile to be eligible for Grant Support to attend CRF meetings including TCT! https://www.tctmd.com/